Medication effect interpretation and the social grid of management

Social Work in Mental Health

Volumn 1, Issue 4, 2004, Pages 71-89

  Longhofer, Jeffrey ^a   Floersch, Jerry ^a   Jenkins, Janis H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248605651     PISSN: 15332985     EISSN: 15332993     Source Type: Journal    
DOI: 10.1300/J200v01n04_05     Document Type: Article

References (45)

1. Ascione, F. (1994). Medication compliance in the elderly. Generations, 18(2), 28-33.
2. Atkin, P. A., & Ogle, S. J. (1996). Issues of medication compliance and the elderly. Adverse Drug Reaction Toxicological Reviews, 15(2), 109-18.
3. Bennett, J., Done, J., & Hunt, B. (1995). Assessing the side-effects of antipsychotic drugs: A survey of community psychiatric nurse practice. Journal of Psychiatric and Mental Health Nursing, 2(3), 177-82.
4. Berg, J. S., Dischler, J., Wagner, D. J., Raia, J. J., & Palmer Shevlin, N. (1993). Medication compliance: A healthcare problem. The Annals of Pharmacotherapy, 27(9 Suppl), 1-24.
5. Boomsma, J., Dassen, T., Dingemans, C., & van den Heuvel, W. (1999). Nursing interventions in crisis-oriented and long-term psychiatric home care. Scandinavian Journal of Caring Sciences, 13(1), 41-8.
6. Cameron, C. (1996). Patient compliance: Recognition of factors involved and suggestions for promoting compliance with therapeutic regimens. Journal of Advanced Nursing, 24, 244-250.
7. Chewning, B. (1997). Patient involvement in pharmaceutical care: A conceptual framework. American Journal of Pharmaceutical Education, 61(4), 394-401.
8. Chewning, B., & Schommer, J. C. (1996). Increasing clients’ knowledge of community pharmacists’ roles. Pharmaceutical Research, 13(9), 1299-1304.
9. Chewning, B., & Sleath, B. (1996). Medication decision-making and management: A client-centered model. Social Science & Medicine, 42(3), 389-398.
10. Cohen, D. (2002). Research on the drug treatment of schizophrenia: A critical appraisal and implications for social work education. Journal ofSocial Work Education 38(2): 217-239.
11. Cohen, D., McCubbin, M., Collin, J., & Perodeau, G. (2001). Medications as social phenomena. Health, 5(4), 441-469.
12. Cohen, J. S., & Insel, P. A. (1996). The physicians’ desk reference-Problems and possible improvements. Archives of Internal Medicine, 156(13), 1375-1380.
13. Conrad, P. (1985). The meaning of medications: Another look at compliance. Social Science and Medicine, 20(1), 29-37.
14. Csordas, T. J. (1990). Embodiment as a paradigm for anthropology. Ethos, 18, 5-47.
15. Csordas, T. J. (1994). Embodiment and experience: The existential ground of culture and self. London: Cambridge University Press.
16. de Vries, C. S., Duggan, C. A., Tromp, T. F. J., & Lolkje, T. W. (1999). Changing prescribing in the light of tolerability concerns: How is this best achieved? Drug Safety, 21(3), 153-160.
17. Demyttenaere, K. (1997). Compliance during treatment with antidepressants. Journal of Affective Disorders, 43, 27-39.
18. Dowell, M. S. (1990). People’s expectations of their medications: An ethnographic study. Ph.D. dissertation, The University of Texas at Austin.
19. Estroff, S. (1981). Making it crazy: An ethnography of psychiatric clients in an American community. Berkeley: University of California Press.
20. Floersch, J. (2002). Meds, money, and manners: The case management of severe mental illness. New York: Coumbia University Press.
21. Floersch, J. (2000). Reading the case record: The oral and written narratives of social workers. Social Service Review, 74(2), 169-192.
22. Good, B. J. (1994). Medicine, rationality, and experience: An anthropological perspective. Cambridge and New York: Cambridge University Press.
23. Gournay, K. (1995). Mental health nurses working purposefully with people with serious and enduring mental illness-An international perspective. International Journal of Nursing Studies, 32(Aug), 341-52.
24. Hamera, E. K., Rhodes, R. M., & Wegner, M. M. (1994). Monitoring of prodromal symptoms: A method for medication management of schizophrenia. CNS Drugs, 2(6), 440-452.
25. Hohmann, A. A., & Shear, M. K. (2002). Community-based intervention research: Coping with the “noise” of real life in study design. American Journal of Psychiatry, 159(2): 201-207.
26. Jenkins, J. H., & Barrett, R. J. (2003). The edge of experience: Schizophrenia, culture, and subjectivity. Medical Anthropology Series Cambridge, UK: Cambridge University Press.
27. Jenkins, J. H., & Miller, D. (2002). A new kind of evidence for mental health services and interventions: Subjective experience of atypical antipsychotic medications. Paper presented at National Institute of Mental Health conference, “Evidenced-Based Practice,” Bethesda, MD. (March).
28. Jordan, S., Hardy, B., & Coleman, M. (1999). Medication management: An exploratory study into the role of community mental health nurses. Journal ofAdvanced Nursing, 29(5): 1068-81.
29. Karp, D. (1996). Speaking of sadness: Depression, disconnection, and the meanings of illness. Oxford: Oxford University Press.
30. Kleinman, A. (1995). Writing at the margin: Discourse between anthropology and medicine. Berkeley: University of California Press.
31. Lipowski, E. (1997). Introducing theories of patient-focused care in pharmaceutical education. American Journal of Pharmaceutical Education, 61, 410-414.
32. Longhofer, J. L., Floersch, J. E., & Jenkins, J. H. (2003). The social grid of community medication management. American Journal of Orthopsychiatry, 73(1): 24-34.
33. Morris, L. S., & Schulz, R. M. (1992). Patient compliance-An overview. Journal of Clinical Pharmacy and Therapeutics, 17, 283-295.
34. Rapp, C. (1998). The strengths model: Case management with people suffering from severe and persistent mental illness. New York: Oxford University Press.
35. Rhodes, L. (1984). This will clear your mind: The use of metaphors for medication in psychiatric settings. Culture, Medicine, & Psychiatry, 8:49-70.
36. Roter, D. L., Hall, J. A., Merisca, R., Nordstrom, B., Cretin, D., & Svarstad, B. (1998). Effectiveness of interventions to improve patient compliance-A meta-analysis. Medical Care, 36(8), 1138-1161.
37. Sleath, B. (1996). Pharmacist-patient relationships: Authoritarian, participatory, or default? Patient Education and Counseling, 28, 253-263.
38. Sleath, B., Svarstad, B., & Roter, D. (1997). Physician vs patient initiation of psychotropic prescribing in primary care settings: A content analysis of audiotapes. Social Science and Medicine, 44(4), 541-548.
39. Sowers, W., & Golden, S. (1999). Psychotropic medication management in persons with co-occurring psychiatric and substance use disorders. Journal of Psychoac- tive-Drugs, Jan-Mar; 31(1): 59-70.
40. Strauss, J. S. (1994). The person with schizophrenia as a person: Approaches to the subjective and complex. British Journal of Psychiatry, 164(suppl. 23), 103-107.
41. Steiner, J. F., & Prochazka, A. V. (1997). The assessment of refill compliance using pharmacy records: Methods, validity, and applications. Journal of Clinical Epidemiology, 50(1), 105-116.
42. Trostle, J. A. (1988). Medical compliance as an ideology. Social Science & Medicine, 27, 1299-1308.
43. Warren, B. J., & Lutz, W. J. (2000). A client-oriented practice model for psychiatric mental health nursing. Archives of Psychiatric Nursing, 14(3), 117-126.
44. Warren, B. J. (1999). Cultural competence in psychiatric nursing: An interlocking paradigm approach. In N. L. Keltner, L. H. Schwecke, & C. E. Bostrom (Eds.), Psychiatric Nursing (pp. 199-218). Chicago: Mosby.
45. Wells, K. B., & Sturm, R. (1996). Informing the policy process: From efficacy to effectiveness data on pharmacotherapy. Journal ofConsulting and Clinical Psychology, 64(4), 638-645.